ArticleScientific reports2025

Silibinin mitigates AKI-to-CKD transition via MAPK and PI3K/AKT signaling pathways in Ischemia-Reperfusion injury.

Sijin Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.